Loomis, Sayles & Company
SYNH

Loomis, Sayles & Company’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Loomis, Sayles & Company’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-93
Closed -$4K – 1043
2023
Q2 		$4K Sell
93
-228
-71% -$9.22K ﹤0.01% 902
2023
Q1 		$11K Buy
321
+267
+494% +$9.69K ﹤0.01% 833
2022
Q4 		$2K Buy
54
+31
+135% +$1.23K ﹤0.01% 828
2022
Q3 		$1K Sell
23
-399,882
-100% -$25.8M ﹤0.01% 942
2022
Q2 		$28.7M Sell
399,905
-2,994
-0.7% -$219K 0.05% 179
2022
Q1 		$32.6M Sell
402,899
-56,032
-12% -$4.74M 0.04% 212
2021
Q4 		$47.1M Sell
458,931
-4,772
-1% -$458K 0.06% 160
2021
Q3 		$40.6M Buy
463,703
+54,728
+13% +$4.95M 0.05% 195
2021
Q2 		$36.6M Buy
408,975
+16,144
+4% +$1.36M 0.04% 222
2021
Q1 		$29.8M Buy
392,831
+212
+0.1% +$16K 0.04% 231
2020
Q4 		$26.7M Buy
392,619
+179,874
+85% +$11.2M 0.04% 225
2020
Q3 		$11.3M Buy
+212,745
New +$12.7M 0.02% 301
2019
Q2 		– Sell
-500
Closed -$26K – 770
2019
Q1 		$26K Buy
500
+288
+136% +$14K ﹤0.01% 592
2018
Q4 		$8K Buy
+212
New +$9.85K ﹤0.01% 804
2017
Q4 		– Sell
-569
Closed -$30K – 965
2017
Q3 		$30K Sell
569
-20
-3% -$1.11K ﹤0.01% 695
2017
Q2 		$34K Sell
589
-89
-13% -$4.63K ﹤0.01% 659
2017
Q1 		$31K Sell
678
-444,282
-100% -$22.1M ﹤0.01% 693
2016
Q4 		$23.4M Buy
444,960
+25,690
+6% +$1.24M 0.06% 224
2016
Q3 		$18.7M Buy
419,270
+29,787
+8% +$1.29M 0.05% 277
2016
Q2 		$14.9M Sell
389,483
-132,921
-25% -$5.84M 0.04% 352
2016
Q1 		$21.5M Sell
522,404
-2,954
-0.6% -$122K 0.06% 238
2015
Q4 		$25.5M Sell
525,358
-2,181
-0.4% -$97K 0.07% 212
2015
Q3 		$21.1M Buy
527,539
+58,583
+12% +$2.56M 0.06% 267
2015
Q2 		$18.8M Buy
+468,956
New +$16.2M 0.05% 340

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Loomis, Sayles & Company's SYNH Position: Q3 2023 in Review

Loomis, Sayles & Company sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 93 shares — an estimated $4K sold.

Loomis, Sayles & Company first reported a position in SYNH in Q2 2015 and held it in 24 quarters. The position peaked at $47.1M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Loomis, Sayles & Company reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 93 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $4K.
  • Loomis, Sayles & Company first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 24 quarters.
  • Loomis, Sayles & Company's Syneos Health, Inc. Class A Common Stock position peaked at $47.1M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Loomis, Sayles & Company's 13F filing for Q3 2023, filed 9 Nov 2023.